A diary,
not a marketplace.

What The Glow Diary is

We are an independent research aggregator and editorial publication. We read studies, regulatory filings, and drug labels so you do not have to, then explain what we found in plain English.

We are not a clinic, pharmacy, telehealth provider, supplement store, or treatment recommendation engine. Nothing published here is medical advice, diagnosis, or a substitute for talking to a licensed clinician who knows your history.

Medical-advice boundary

There is a line between explaining what published evidence says and telling you what to do with your body. We stay on the explaining side.

What we do: Summarize what clinical trials, regulatory labels, and systematic reviews report. Flag when evidence is strong, weak, missing, or contradictory. Point out what is still unknown. Suggest questions worth bringing to a healthcare provider.

What we never do: Recommend specific doses, protocols, or treatment plans for individuals. Claim any intervention is safe, approved, or superior without citing a specific source. Provide personalized medical guidance through articles, email, or any other channel. Fabricate clinician endorsements, staff credentials, or advisory relationships.

If you are making a decision about medication, supplements, procedures, or any health intervention, the right next step is a conversation with a qualified healthcare provider, not another article.

Evidence hierarchy

Not all sources carry the same weight. We grade the evidence behind every substantive claim.

Grade A (strong evidence): Large randomized controlled trials, systematic reviews, meta-analyses, and official regulatory labels (FDA, EMA). Multiple independent studies reaching consistent conclusions. We state findings directly.

Grade B (moderate evidence): Individual randomized trials with smaller samples, well-designed observational or cohort studies, and registry-based analyses. Evidence that is consistent but limited in scope or population. We state what the evidence shows but flag the limitations.

Grade C (preliminary or signal-level): Case reports, small open-label studies, mechanistic or preclinical research (animal and in-vitro), conference abstracts, and retrospective analyses. The signal exists but is not strong enough for firm conclusions.

Grade D (anecdotal, promotional, or unverified): Social media anecdotes, clinic marketing materials, influencer protocols, press releases, and sponsor-funded content. We do not cite this as evidence. We may reference it to describe what people are asking about, but we always separate it clearly from published research.

Source transparency

Every article that makes a substantive health claim includes the sources we relied on, linked or cited by stable identifier (PMID, DOI, NCT ID, FDA SET ID, or URL). It includes the evidence grade assigned to each major claim, the date we last reviewed the sources, and a note on any conflicting evidence we found.

When we reference a source, we link to the original whenever possible. We do not rely solely on secondary summaries, news coverage, or press releases for scientific claims.

Corrections and updates

Research moves. Labels change. Trials publish new results. Our articles are not frozen in time.

If we learn that a factual claim is wrong, we correct it promptly and note the change at the bottom of the article with the date and what changed. If a correction affects a substantive health or safety claim, it appears prominently, not buried in a footnote.

Each article displays a "last reviewed" date. We aim to re-review articles at least every 90 days for active topics (GLP-1s, semaglutide, tirzepatide) and every 180 days for less rapidly evolving topics. If a major regulatory change, recall, or new pivotal trial is published, we prioritize updating affected articles regardless of the scheduled review date. We note the review history on each article so readers can see when something was last checked.

Conflict disclosures

The Glow Diary is owned and operated by Excelsior Creative LLC. As of this writing, we have no financial relationships with pharmaceutical companies, device manufacturers, compounding pharmacies, supplement brands, clinics, or telehealth providers.

If that changes, we will disclose any financial relationship that could reasonably be perceived as influencing our coverage, including advertising or sponsorship agreements, affiliate or referral arrangements, consulting relationships, and free products provided for review. Disclosures will appear on the relevant article page and on this page.

We do not accept payment to write favorable coverage, suppress negative findings, or alter evidence grades.

Advertising and sponsorship boundaries

When we eventually accept advertising or sponsorships, they will be clearly separated from editorial content. Ads and sponsored content will be visually distinct and labeled. Sponsor relationships will not influence evidence grades, verdicts, or safety language. We will not run ads for specific drugs, peptides, or prescription products directly adjacent to articles about those products. Any affiliate or referral relationship will be disclosed before the reader encounters the link.

These boundaries are non-negotiable regardless of revenue impact.

Localization and translation

When we publish content in languages other than English, it will be written or reviewed by someone fluent in the target language, not machine-translated and published without review. Medical and regulatory terms will be verified for accuracy in the target language and regulatory context. Each translated article will carry its own review date and review status. If a claim depends on country-specific regulation (e.g., FDA vs. EMA approval status), we will note the relevant jurisdiction.

Who writes this

Articles are written by our editorial team. Author names appear on every article. If an article references a credentialed reviewer or contributor, that person's actual credentials and relationship to The Glow Diary are stated accurately. We do not invent reviewers, medical directors, or advisory boards.

These standards are a living document. Last updated: May 2026. If you believe we have fallen short of any standard described here, email editorial@glowdiary.org.